



Other version: https://academic.oup.com/cid/article/69/9/1489/5269466
Dataset: https://academic.oup.com/cid/article/69/9/1489/5269466#supplementary-data
![]() |
Non-inferiority of simplified dolutegravir monotherapy compared to continued combination antiretroviral therapy that was initiated during primary HIV infection: a randomized, controlled, multi-site, open-label, non-inferiority trial |
|
Authors | ![]() | |
Published in | Clinical infectious diseases. 2019, vol. 69, no. 9, p. 1489-1497 | |
Abstract | Patients who start combination antiretroviral therapy (cART) during primary HIV-1 infection show a smaller HIV-1 latent reservoir, less immune activation and a smaller viral diversity compared to patients who start cART during chronic infection. We conducted a pilot study to test whether these properties would allow sustained virological suppression after simplification of cART to dolutegravir monotherapy. | |
Keywords | Primary HIV infection — Dolutegravir — Monotherapy — Simplification — Randomized controlled trial | |
Identifiers | DOI: 10.1093/cid/ciy1131 PMID: 30601950 | |
Full text |
![]() ![]() ![]() ![]() Other version: https://academic.oup.com/cid/article/69/9/1489/5269466 Dataset: https://academic.oup.com/cid/article/69/9/1489/5269466#supplementary-data |
|
Structures | ||
Research group | Maladies infectieuses et modèles mathématiques (988) | |
Projects | Swiss National Science Foundation: 179571 Swiss National Science Foundation: PZ00P3_142411 Swiss National Science Foundation: BSSGI0_155851 Swiss National Science Foundation: 324730_165956 | |
Citation (ISO format) | BRAUN, Dominique L et al. Non-inferiority of simplified dolutegravir monotherapy compared to continued combination antiretroviral therapy that was initiated during primary HIV infection: a randomized, controlled, multi-site, open-label, non-inferiority trial. In: Clinical Infectious Diseases, 2019, vol. 69, n° 9, p. 1489-1497. doi: 10.1093/cid/ciy1131 https://archive-ouverte.unige.ch/unige:125267 |